BPM
AMRX icon

Bowling Portfolio Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bowling Portfolio Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,253
Closed -$93K – 191
2022
Q1 		$93K Buy
22,253
+3,615
+19% +$16K 0.02% 197
2021
Q4 		$89K Sell
18,638
-345
-2% -$1.72K 0.02% 203
2021
Q3 		$101K Hold
18,983
– – 0.02% 201
2021
Q2 		$97K Buy
+18,983
New +$108K 0.02% 202

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bowling Portfolio Management's AMRX Position: Q2 2022 in Review

Bowling Portfolio Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2022, closing a stake of 22,253 shares — an estimated $93K sold.

Bowling Portfolio Management first reported a position in AMRX in Q2 2021 and held it in 4 quarters. The position peaked at $101K in Q3 2021. 153 funds tracked by Wall St. Rank hold AMRX as of Q2 2022.

  • Bowling Portfolio Management reported no remaining Amneal Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Bowling Portfolio Management sold 22,253 Amneal Pharmaceuticals shares in Q2 2022, an estimated $93K.
  • Bowling Portfolio Management first reported a position in Amneal Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Bowling Portfolio Management's Amneal Pharmaceuticals position peaked at $101K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2022.

Based on Bowling Portfolio Management's 13F filing for Q2 2022, filed 21 Jul 2022.